Castagna Michael

Avg. Two Year Performance

(57%) Avg. Purchase Return
(25%) Compound
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return(10%)(14%)(33%)(66%)(57%)
Purchase Success Rate2 of 42 of 40 of 40 of 40 of 4
Average Sale Return----------
Sale Success Rate----------
Drugs » Biotechnology

Chief Executive Officer, Director:

Holdings: 203.56K shares


Insider Trading Sentiment: Accumulate

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

$6.25K Net Amount